GlassScriptPhysician profile
Caitlin K Dillon
NPI 1104232180
$1,461.87
in general payments reported to CMS, 2019-2025
21 companies · $12.00 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $280 · 2021: $82.45 · 2022: $208 · 2023: $194 · 2024: $120 · 2025: $12.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $220.35 | 2019-2024 | Wegovy |
| Janssen Biotech, INC. | $217.06 | 2020-2021 | |
| Melinta Therapeutics, LLC | $198.43 | 2019 | |
| Abbott Laboratories | $121.31 | 2022-2023 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $113.48 | 2023-2024 | Inspire |
| Paratek Pharmaceuticals, INC. | $97.27 | 2021-2023 | Nuzyra |
| Tetraphase Pharmaceuticals, INC. | $84.22 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.11 | 2022 | |
| Lilly USA, LLC | $56.70 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $55.28 | 2019 | |
| Viiv Healthcare Company | $46.97 | 2020 | |
| Amgen INC. | $29.62 | 2019 | |
| Glaxosmithkline, LLC. | $21.30 | 2019 | |
| Dexcom, INC. | $21.15 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $19.42 | 2024 | Cologuard Collection Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $15.83 | 2019 | |
| Amarin Pharma, INC. | $14.75 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.10 | 2019 | |
| Tms Neurohealth Centers INC. | $12.00 | 2025 | Tms Neurohealth Centers INC. |
| Ironwood Pharmaceuticals, INC | $11.97 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.